Selective ghrelin receptor agonist MK-677 improves IGF-1 levels in GH-deficient adults
Clinical Endocrinology
2002
Study summary
Study evaluating MK-677 in adults with GH deficiency.
Peptides studied
Stack studied
Performance Stack
Key findings
Increased circulating IGF-1 and improved body composition markers.
Study details
Study type
human clinical trial
Journal
Clinical Endocrinology
DOI / PubMed
PMID:12466356
Year
2002
Explore peptide profiles
Discover compounds, understand their mechanisms, and explore the research behind each peptide.
